233 related articles for article (PubMed ID: 37994750)
21. Application of omics technologies in dermatological research and skin management.
He J; Jia Y
J Cosmet Dermatol; 2022 Feb; 21(2):451-460. PubMed ID: 33759323
[TBL] [Abstract][Full Text] [Related]
22. Proteomic research in sarcomas - current status and future opportunities.
Burns J; Wilding CP; L Jones R; H Huang P
Semin Cancer Biol; 2020 Apr; 61():56-70. PubMed ID: 31722230
[TBL] [Abstract][Full Text] [Related]
23. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
Ahmed Z
Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
[TBL] [Abstract][Full Text] [Related]
24. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
25. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
26. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
27. From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.
Nevedomskaya E; Haendler B
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682963
[TBL] [Abstract][Full Text] [Related]
28. Biological determinants of health: Genes, microbes, and metabolism exemplars of nursing science.
Ferranti EP; Grossmann R; Starkweather A; Heitkemper M
Nurs Outlook; 2017; 65(5):506-514. PubMed ID: 28576296
[TBL] [Abstract][Full Text] [Related]
29. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
30. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
[TBL] [Abstract][Full Text] [Related]
31. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
32. Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.
Guang MHZ; McCann A; Bianchi G; Zhang L; Dowling P; Bazou D; O'Gorman P; Anderson KC
Leuk Lymphoma; 2018 Mar; 59(3):542-561. PubMed ID: 28610537
[TBL] [Abstract][Full Text] [Related]
33. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
34. Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.
Guan F; Ni T; Zhu W; Williams LK; Cui LB; Li M; Tubbs J; Sham PC; Gui H
Mol Psychiatry; 2022 Jan; 27(1):113-126. PubMed ID: 34193973
[TBL] [Abstract][Full Text] [Related]
35. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract][Full Text] [Related]
37. Personalized Medicine Applied to Forensic Sciences: New Advances and Perspectives for a Tailored Forensic Approach.
Santurro A; Vullo AM; Borro M; Gentile G; La Russa R; Simmaco M; Frati P; Fineschi V
Curr Pharm Biotechnol; 2017; 18(3):263-273. PubMed ID: 28176637
[TBL] [Abstract][Full Text] [Related]
38. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management.
Srivastava S; Jayaswal N; Kumar S; Sharma PK; Behl T; Khalid A; Mohan S; Najmi A; Zoghebi K; Alhazmi HA
Cell Signal; 2024 Jan; 113():110932. PubMed ID: 37866667
[TBL] [Abstract][Full Text] [Related]
39. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
Ahmed Z
Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
